girentuximab (cG250)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for girentuximab (cG250), covering 2013-12-02 to 2013-12-02. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250 [NA]